| Product Code: ETC13117654 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Portugal continued to heavily rely on imports for pneumococcal vaccines, with the top exporting countries being the Netherlands, Spain, USA, Sweden, and the UK. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), significantly increased from 2023 to 2024, indicating a very high level of concentration among suppliers. Despite a remarkable compound annual growth rate (CAGR) of 56.26% from 2020 to 2024, the growth rate saw a slight decline of -4.78% in 2024. This data suggests that while the market for pneumococcal vaccines in Portugal is expanding rapidly, there may be some shifts in supplier dynamics impacting
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal Pneumococcal Vaccines Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal Pneumococcal Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Portugal Pneumococcal Vaccines Market - Industry Life Cycle |
3.4 Portugal Pneumococcal Vaccines Market - Porter's Five Forces |
3.5 Portugal Pneumococcal Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Portugal Pneumococcal Vaccines Market Revenues & Volume Share, By Vaccine Technology, 2021 & 2031F |
3.7 Portugal Pneumococcal Vaccines Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Portugal Pneumococcal Vaccines Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Portugal Pneumococcal Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing pneumococcal diseases |
4.2.2 Government initiatives and funding to promote vaccination programs |
4.2.3 Growing prevalence of pneumococcal diseases in Portugal |
4.3 Market Restraints |
4.3.1 High cost associated with pneumococcal vaccines |
4.3.2 Limited access to healthcare services in certain regions of Portugal |
4.3.3 Concerns about the safety and efficacy of pneumococcal vaccines |
5 Portugal Pneumococcal Vaccines Market Trends |
6 Portugal Pneumococcal Vaccines Market, By Types |
6.1 Portugal Pneumococcal Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Portugal Pneumococcal Vaccines Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Portugal Pneumococcal Vaccines Market Revenues & Volume, By Conjugate, 2021 - 2031F |
6.1.4 Portugal Pneumococcal Vaccines Market Revenues & Volume, By Polysaccharide, 2021 - 2031F |
6.1.5 Portugal Pneumococcal Vaccines Market Revenues & Volume, By Combination, 2021 - 2031F |
6.1.6 Portugal Pneumococcal Vaccines Market Revenues & Volume, By Live Attenuated, 2021 - 2031F |
6.1.7 Portugal Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Portugal Pneumococcal Vaccines Market, By Vaccine Technology |
6.2.1 Overview and Analysis |
6.2.2 Portugal Pneumococcal Vaccines Market Revenues & Volume, By Protein-based, 2021 - 2031F |
6.2.3 Portugal Pneumococcal Vaccines Market Revenues & Volume, By Recombinant, 2021 - 2031F |
6.2.4 Portugal Pneumococcal Vaccines Market Revenues & Volume, By Inactivated, 2021 - 2031F |
6.2.5 Portugal Pneumococcal Vaccines Market Revenues & Volume, By mRNA-based, 2021 - 2031F |
6.2.6 Portugal Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 Portugal Pneumococcal Vaccines Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Portugal Pneumococcal Vaccines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Portugal Pneumococcal Vaccines Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Portugal Pneumococcal Vaccines Market Revenues & Volume, By Government, 2021 - 2031F |
6.3.5 Portugal Pneumococcal Vaccines Market Revenues & Volume, By NGOs, 2021 - 2031F |
6.3.6 Portugal Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.4 Portugal Pneumococcal Vaccines Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Portugal Pneumococcal Vaccines Market Revenues & Volume, By Immunization, 2021 - 2031F |
6.4.3 Portugal Pneumococcal Vaccines Market Revenues & Volume, By Disease Prevention, 2021 - 2031F |
6.4.4 Portugal Pneumococcal Vaccines Market Revenues & Volume, By Pediatric Vaccination, 2021 - 2031F |
6.4.5 Portugal Pneumococcal Vaccines Market Revenues & Volume, By Elderly Care, 2021 - 2031F |
6.4.6 Portugal Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
7 Portugal Pneumococcal Vaccines Market Import-Export Trade Statistics |
7.1 Portugal Pneumococcal Vaccines Market Export to Major Countries |
7.2 Portugal Pneumococcal Vaccines Market Imports from Major Countries |
8 Portugal Pneumococcal Vaccines Market Key Performance Indicators |
8.1 % of population vaccinated against pneumococcal diseases |
8.2 Number of healthcare facilities offering pneumococcal vaccination services |
8.3 Number of reported cases of pneumococcal diseases in Portugal |
9 Portugal Pneumococcal Vaccines Market - Opportunity Assessment |
9.1 Portugal Pneumococcal Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Portugal Pneumococcal Vaccines Market Opportunity Assessment, By Vaccine Technology, 2021 & 2031F |
9.3 Portugal Pneumococcal Vaccines Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Portugal Pneumococcal Vaccines Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Portugal Pneumococcal Vaccines Market - Competitive Landscape |
10.1 Portugal Pneumococcal Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Portugal Pneumococcal Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here